hPMSCs protects against d-galactose-induced oxidative damage of CD4+ T cells through activating Akt-mediated Nrf2 antioxidant signalingYanlian Xiong, Xiying Luan, YUEMING WANG et al.|Stem Cell Research & Therapy|2020Cited by 31
hPMSCs inhibit the expression of PD-1 in CD4+IL-10+ T cells and mitigate liver damage in a GVHD mouse model by regulating the crosstalk between Nrf2 and NF-κB signaling pathwayAiping Zhang, Xiying Luan, Xiaohua Li et al.|Stem Cell Research & Therapy|2021Cited by 31
IL-27 Promotes Human Placenta–Derived Mesenchymal Stromal Cell Ability To Induce the Generation of CD4+IL-10+IFN-γ+ T Cells via the JAK/STAT Pathway in the Treatment of Experimental Graft-versus-Host DiseaseJunzhu Yi, Xiying Luan, Zhenghua Chen et al.|The Journal of Immunology|2019Cited by 26
IL-1β enhances human placenta-derived mesenchymal stromal cells ability to mediate Th1/Th2 and Th1/CD4+IL-10+ T cell balance and regulates its adhesion, proliferation and migration via PD-L1Aiping Zhang, Xiying Luan, Yanlian Xiong et al.|Cellular Immunology|2020Cited by 22
HPMSCs Inhibit the Expression of PD-1 in CD4+IL-10+ T Cells and Mitigate liver Damage in a GVHD Mouse Model by Regulating the Cross-talk Between Nrf2 and NF-κB Signaling PathwayAiping Zhang, Xiying Luan, Xiaohua Li et al.|Research Square|2021Cited by 0